FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204288598> ?p ?o ?g. }

• W3204288598 endingPage "1705" @default.
• W3204288598 startingPage "1679" @default.
• W3204288598 abstract "Chronic lymphocytic leukemia (CLL) is one of the most frequent types of leukemia. It typically occurs in elderly patients and has a highly variable clinical course. Leukemic transformation is initiated by specific genomic alterations that interfere with the regulation of proliferation and of apoptosis in clonal B-cells.The diagnosis is established by blood counts, blood smears, and immunophenotyping of circulating B-lymphocytes, which identify a clonal B-cell population carrying the CD5 antigen as well as typical B-cell markers.The clinical staging systems provide prognostic information by using the results of physical examination and blood counts. Various biological and genetic markers provide additional prognostic information. Deletions of the short arm of chromosome 17 (del[17p]) and/or mutations of the TP53 gene predict resistance to chemoimmunotherapy and a shorter time to progression with most targeted therapies. The CLL international prognostic index integrates genetic, biological, and clinical variables to identify distinct risk groups of patients with CLL.Only patients with active or symptomatic disease or with advanced Binet or Rai stages require therapy. When treatment is indicated, several therapeutic options exist: a combination of the B-cell lymphoma 2 (BCL2) inhibitor venetoclax with obinutuzumab, monotherapy with inhibitors of Bruton tyrosine kinase (BTK) such as ibrutinib and acalabrutinib, or chemoimmunotherapy. At relapse, the initial treatment may be repeated, if the treatment-free interval exceeds 3 years. If the disease relapses earlier, therapy should be changed using an alternative regimen. Patients with a del(17p) or TP53 mutation are usually resistant to chemotherapy and should, therefore, be treated with targeted agents.Combinations of targeted agents are now being investigated to create efficient, potentially curative therapies of CLL with fixed duration. One of the most relevant questions currently addressed in clinical trials is the comparison of monotherapies with BTK inhibitors with fixed duration combination therapies. Moreover, the optimal sequencing of targeted therapies remains to be determined. Alternative therapies are needed for patients with BTK and BCL2 inhibitor double-refractory disease." @default.
• W3204288598 created "2021-10-11" @default.
• W3204288598 creator A5076077834 @default.
• W3204288598 creator A5085633786 @default.
• W3204288598 date "2021-11-24" @default.
• W3204288598 modified "2023-10-14" @default.
• W3204288598 title "Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures" @default.
• W3204288598 cites W1509374036 @default.
• W3204288598 cites W154103547 @default.
• W3204288598 cites W1545944104 @default.
• W3204288598 cites W1584622450 @default.
• W3204288598 cites W1833241997 @default.
• W3204288598 cites W1891680586 @default.
• W3204288598 cites W1938426499 @default.
• W3204288598 cites W1942856476 @default.
• W3204288598 cites W1957256977 @default.
• W3204288598 cites W1964228724 @default.
• W3204288598 cites W1964899672 @default.
• W3204288598 cites W1965851569 @default.
• W3204288598 cites W1967008538 @default.
• W3204288598 cites W1968458944 @default.
• W3204288598 cites W1970312642 @default.
• W3204288598 cites W1972073735 @default.
• W3204288598 cites W1985492078 @default.
• W3204288598 cites W1988217711 @default.
• W3204288598 cites W1993355130 @default.
• W3204288598 cites W1993986769 @default.
• W3204288598 cites W1994709165 @default.
• W3204288598 cites W1996593839 @default.
• W3204288598 cites W1999128869 @default.
• W3204288598 cites W1999977012 @default.
• W3204288598 cites W2001453633 @default.
• W3204288598 cites W2001850157 @default.
• W3204288598 cites W2002404007 @default.
• W3204288598 cites W2005092974 @default.
• W3204288598 cites W2012228539 @default.
• W3204288598 cites W2012721290 @default.
• W3204288598 cites W2015120596 @default.
• W3204288598 cites W2018756833 @default.
• W3204288598 cites W2019274594 @default.
• W3204288598 cites W2020069805 @default.
• W3204288598 cites W2021628104 @default.
• W3204288598 cites W2022054497 @default.
• W3204288598 cites W2026597875 @default.
• W3204288598 cites W2026805676 @default.
• W3204288598 cites W2031121711 @default.
• W3204288598 cites W2034165114 @default.
• W3204288598 cites W2035918677 @default.
• W3204288598 cites W2037461427 @default.
• W3204288598 cites W2037525909 @default.
• W3204288598 cites W2037648016 @default.
• W3204288598 cites W2038053631 @default.
• W3204288598 cites W2038678963 @default.
• W3204288598 cites W2049372901 @default.
• W3204288598 cites W2055886080 @default.
• W3204288598 cites W2058786179 @default.
• W3204288598 cites W2061249695 @default.
• W3204288598 cites W2066564017 @default.
• W3204288598 cites W2067064694 @default.
• W3204288598 cites W2070193300 @default.
• W3204288598 cites W2071549499 @default.
• W3204288598 cites W2074584895 @default.
• W3204288598 cites W2075875145 @default.
• W3204288598 cites W2078249396 @default.
• W3204288598 cites W2079481807 @default.
• W3204288598 cites W2086296392 @default.
• W3204288598 cites W2089298737 @default.
• W3204288598 cites W2091057822 @default.
• W3204288598 cites W2095447519 @default.
• W3204288598 cites W2096082426 @default.
• W3204288598 cites W2097852595 @default.
• W3204288598 cites W2099145932 @default.
• W3204288598 cites W2105044162 @default.
• W3204288598 cites W2105773020 @default.
• W3204288598 cites W2106233921 @default.
• W3204288598 cites W2107567250 @default.
• W3204288598 cites W2108206643 @default.
• W3204288598 cites W2111403010 @default.
• W3204288598 cites W2116248495 @default.
• W3204288598 cites W2116835043 @default.
• W3204288598 cites W2120319857 @default.
• W3204288598 cites W2122725450 @default.
• W3204288598 cites W2124221273 @default.
• W3204288598 cites W2124575836 @default.
• W3204288598 cites W2126322093 @default.
• W3204288598 cites W2126442701 @default.
• W3204288598 cites W2129041705 @default.
• W3204288598 cites W2129285584 @default.
• W3204288598 cites W2130011407 @default.
• W3204288598 cites W2131823788 @default.
• W3204288598 cites W2132433919 @default.
• W3204288598 cites W2134057518 @default.
• W3204288598 cites W2134538858 @default.
• W3204288598 cites W2135270635 @default.
• W3204288598 cites W2135314242 @default.
• W3204288598 cites W2135551958 @default.
• W3204288598 cites W2136242714 @default.
• W3204288598 cites W2136272158 @default.

• next